Aspen Pharmacare Holdings Limited (JSE:APN) News - Vesting of securities for directors, company secretary and prescribed officers of the company ASPEN PHARMACARE HOLDINGS LIMITED (Incorporated in the Republic of South Africa) (“Aspen Holdings”) Registration number: 1985/002935/06 Share code: APN ISIN: ZAE000066692 LEI: 635400ZYSN1IRD5QWQ94 (“Aspen” or “the Company”) VESTING OF SECURITIES FOR DIRECTORS, COMPANY SECRETARY AND PRESCRIBED OFFICERS OF THE COMPANY In compliance with paragraph 3.63 of the Listings Requirements of the JSE Limited, disclosure is made of the following information: Deferred bonus shares, awarded in 2018 in respect of the Aspen South African Management Deferred Incentive Scheme, vested in October 2021, but were not delivered to the undermentioned directors, company secretary, and prescribed officers of the Company, due to the Company trading under a cautionary announcement, followed by a closed period for trade. These shares have now been delivered and accepted by the undermentioned directors, company secretary, and prescribed officers of the Company, due to there being no applicable prohibited or closed period for trade. Name : Sean Matthew Capazorio – Director Company : Aspen Pharmacare Holdings Limited Date of transaction : 1 April 2022 Shares to be delivered – off market : 6 660 Vesting Price (Oct 2021) : R 256.00 Value of shares – vested : R 1 704 960.00 Release Price (Mar 2022) : R 183.57 Value of shares – released : R 1 222 576.20 Class of securities : Ordinary shares Nature of interest : Direct beneficial Clearance obtained : Not applicable – no dealing by director involved Director : Stephen Bradley Saad Company : Aspen Pharmacare Holdings Limited Date of transaction : 1 April 2022 Shares to be delivered – off market : 14 352 Vesting Price (Oct 2021) : R 256.00 Value of shares – at vesting : R 3 674 112.00 Release Price (Mar 2022) : R 183.57 Value of shares – released : R 2 634 596.64 Class of securities : Ordinary shares Nature of interest : Direct beneficial Clearance obtained : Not applicable – no dealing by director involved Name : Riaan Verster – Company Secretary Company : Aspen Pharmacare Holdings Limited Date of transaction : 1 April 2022 Shares to be delivered – off market : 2 477 Vesting Price (Oct 2021) : R 256.00 Value of shares – vested : R 634 112.00 Release Price (Mar 2022) : R 183.57 Value of shares – released : R 454 702.89 Class of securities : Ordinary shares Nature of interest : Direct beneficial Clearance obtained : Not applicable – no dealing by company secretary involved Name : Michael Guy Attridge – Prescribed Officer Company : Aspen Pharmacare Holdings Limited Date of transaction : 1 April 2022 Shares to be delivered – off market : 11 864 Vesting Price (Oct 2021) : R 256.00 Value of shares – at vesting : R 3 037 184.00 Release Price (Mar 2022) : R 183.57 Value of shares – released : R 2 177 874.48 Class of securities : Ordinary shares Nature of interest : Direct beneficial Clearance obtained : Not applicable – no dealing by prescribed officer involved Name : Lorraine Angela Hill – Prescribed Officer Company : Aspen Pharmacare Holdings Limited Date of transaction : 1 April 2022 Shares to be delivered – off market : 9 564 Vesting Price (Oct 2021) : R 256.00 Value of shares to be delivered : R 2 448 384.00 Release Price (Mar 2022) : R 183.57 Value of shares – released : R 1 755 663.48 Class of securities : Ordinary shares Nature of interest : Direct beneficial Clearance obtained : Not applicable – no dealing by prescribed officer involved Durban 01 April 2022 Sponsor Investec Bank Limited Date: 01-04-2022 05:00:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on, information disseminated through SENS.